MRI primary breast lesion volume has been shown to be a strong predictor in the response to chemotherapy for invasive breast cancer. However, the prediction accuracy remains low. In this study, we investigated the feasibility of using lymph node volume and signal enhancement ratio as predictors of the chemotherapy response. The result shows that the lymph nodes signal-enhancement ratio is a stronger predictor than lymph node volume and primary in-breast lesion volume.
This abstract and the presentation materials are available to members only; a login is required.